|
Terrance H. Gregg is President & CEO of DexCom, Inc. He is also currently a Special Venture Partner with Galen-Partners, a private equity firm specializing in the healthcare industry.
In 2002 he retired as President of Medtronic MiniMed, a world leader in diabetes management systems. He became President and Chief Operating Officer of MiniMed Inc in 1996 and was instrumental in Medtronic’s $3.4 billion acquisition of MiniMed in 2001. He also served in executive positions with Smith & Nephew and Allergan, Inc.
Mr. Gregg served as the 2003-2004 Chair of the Research Foundation Board of the American Diabetes Association and serves on the boards of Vasogen, Inc., and LMS Medical Systems.
Mr. Gregg received a Bachelor of Science degree from Colorado State University in 1971. In 2003, Mr. Gregg and his wife were recognized by the American Diabetes Association with an award for Outstanding Service in Diabetes Research Funding. | 